Harrow, Inc. Employee Count
The employee counts Harrow, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2023-12-31: Employees (as filed) 315; Filing 2024-03-19.
- 2022-12-31: Employees (as filed) 217; Filing 2023-03-23.
- 2021-12-31: Employees (as filed) 182; Filing 2022-03-10; Lease expense per employee $5.49.
- 2020-12-31: Employees (as filed) 125; Filing 2021-03-08; Lease expense per employee $80.00.
- Available history
- 2015-12-31 to 2023-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2023-12-31 | 315 | 2024-03-19 | |
| 2022-12-31 | 217 | 2023-03-23 | |
| 2021-12-31 | 182 | 2022-03-10 | $5.49 finance interest |
| 2020-12-31 | 125 | 2021-03-08 | $80.00 finance amortization + finance interest |
| 2019-12-31 | 133 | 2020-03-13 | $1,263.16 finance amortization + finance interest |
| 2018-12-31 | 134 | 2019-03-12 | $5,410.45 rent expense, net |
| 2017-12-31 | 128 | 2018-03-08 | $5,070.31 rent expense, net |
| 2016-12-31 | 144 full-time | 2017-03-21 | $4,638.89 rent expense, net |
| 2015-12-31 | 112 full-time | 2016-03-23 | $5,723.21 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |